Medulloblastoma — Trials

Medulloblastoma — Trials · CancerIndex

Clinical trials

Registered studies

204 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 29
Ph III recruiting: 2
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07346157	Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease(PNOC044)	recruiting	Phase 1 / Phase 2	69	Sabine Mueller, MD, PhDOTHER	1	Sep 28, 2026	clinicaltrials
NCT06804655	Pharmacoscopy for Patients With Refractory Primary Brain Tumors(EViDENCE-BT)	recruiting	Phase 2	40	University of ZurichOTHER	1	Sep 21, 2026